{
  "input": {
    "mode": "revise",
    "query": {
      "entity": "Familial pulmonary fibrosis",
      "relation": "contraindication"
    },
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_abatacept",
          "type": "Drug",
          "label": "Abatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_anakinra",
          "type": "Drug",
          "label": "Anakinra",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_daclizumab",
          "type": "Drug",
          "label": "Daclizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_teriflunomide",
          "type": "Drug",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_familial_pulmonary_fibrosis",
          "type": "Disease",
          "label": "Familial pulmonary fibrosis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ot1",
          "type": "Target",
          "label": "Increased Fibrosis Risk",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_ot2",
          "type": "Target",
          "label": "Immunosuppression",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "n_adv1",
          "type": "Phenotype",
          "label": "Exacerbation of Pulmonary Fibrosis",
          "attrs": {
            "agent": "Skeptic"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Abatacept",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_abatacept",
          "type": "Drug",
          "label": "Abatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Adalimumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_adalimumab",
          "type": "Drug",
          "label": "Adalimumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Anakinra",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_anakinra",
          "type": "Drug",
          "label": "Anakinra",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Azathioprine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_azathioprine",
          "type": "Drug",
          "label": "Azathioprine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Bosentan",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bosentan",
          "type": "Drug",
          "label": "Bosentan",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Daclizumab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_daclizumab",
          "type": "Drug",
          "label": "Daclizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Methotrexate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methotrexate",
          "type": "Drug",
          "label": "Methotrexate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Nintedanib",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_nintedanib",
          "type": "Drug",
          "label": "Nintedanib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_pirfenidone",
          "type": "Drug",
          "label": "Pirfenidone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Rituximab",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_teriflunomide",
          "type": "Drug",
          "label": "Teriflunomide",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "n_abatacept",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "已知对免疫抑制相关疾病有风险"
        },
        {
          "source": "n_adalimumab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindicaiton",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "可能导致病情加重"
        },
        {
          "source": "n_anakinra",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "对肺部纤维化的影响尚不明确"
        },
        {
          "source": "n_azathioprine",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "已知有肺部副作用"
        },
        {
          "source": "n_bosentan",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "可能影响肺血流"
        },
        {
          "source": "n_cyclophosphamide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "已知对免疫系统影响较大"
        },
        {
          "source": "n_daclizumab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "风险未明确评估"
        },
        {
          "source": "n_methotrexate",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "已知肺部副作用"
        },
        {
          "source": "n_nintedanib",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "更需评估安全性"
        },
        {
          "source": "n_pirfenidone",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "可能加重病情"
        },
        {
          "source": "n_rituximab",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "对肺部损害风险"
        },
        {
          "source": "n_teriflunomide",
          "target": "n_familial_pulmonary_fibrosis",
          "relation": "contraindication",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "影响未详尽研究"
        },
        {
          "source": "drug_abatacept",
          "target": "n_ot1",
          "relation": "acts_on",
          "weight": 0.7,
          "agent": "Skeptic",
          "rationale": "已知风险与疾病进展相关"
        },
        {
          "source": "drug_abatacept",
          "target": "n_ot2",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Skeptic",
          "rationale": "可能导致免疫抑制，增加感染风险"
        },
        {
          "source": "n_ot1",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Skeptic",
          "rationale": "可能加重肺纤维化临床表现"
        },
        {
          "source": "n_ot2",
          "target": "n_adv1",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Skeptic",
          "rationale": "免疫抑制可能导致病情恶化"
        },
        {
          "source": "n_adv1",
          "target": "H1",
          "relation": "refutes",
          "weight": 0.9,
          "agent": "Skeptic",
          "rationale": "风险存在可能抵消潜在益处"
        }
      ],
      "round_index": 2
    },
    "history": {
      "round": 2,
      "last_scores": [
        {
          "hypothesis_id": "H1",
          "score": 0.51,
          "components": {
            "mechanism_fit": 0.6,
            "class_prior": 0.5,
            "pk_pd_feasibility": 0.7,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.1
          },
          "graph_signals": {
            "support_weight": 0.8,
            "contradiction_weight": 0.9,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_abatacept"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Abatacept与免疫抑制有风险，但影响尚不明确。"
            ],
            "safety_risk": [
              "已知加重肺纤维化，反对使用。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需要进一步证据确定具体影响"
          ]
        },
        {
          "hypothesis_id": "H2",
          "score": 0.47,
          "components": {
            "mechanism_fit": 0.5,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.5,
            "safety_risk": 0.3,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.75,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_adalimumab"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "Adalimumab可能导致病情加重。"
            ],
            "safety_risk": [
              "对肺部纤维化影响尚不明确。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏特定研究数据"
          ]
        },
        {
          "hypothesis_id": "H3",
          "score": 0.45,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.4,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.4,
            "safety_risk": 0.4,
            "graph_bonus": 0.05,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.7,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_anakinra"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "对肺部纤维化影响需要进一步研究。"
            ],
            "safety_risk": [
              "存在不确定风险，需谨慎使用。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏足够临床数据支持"
          ]
        },
        {
          "hypothesis_id": "H4",
          "score": 0.43,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.5,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.03,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_azathioprine"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已知有肺部副作用，需谨慎使用。"
            ],
            "safety_risk": [
              "可能导致免疫系统问题。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需更多证据评估安全性"
          ]
        },
        {
          "hypothesis_id": "H5",
          "score": 0.41,
          "components": {
            "mechanism_fit": 0.4,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.6,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_bosentan"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "可能影响肺血流并加重病情。"
            ],
            "safety_risk": [
              "已知具有副作用风险。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏数据评价其对肺部健康的影响"
          ]
        },
        {
          "hypothesis_id": "H6",
          "score": 0.38,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_cyclophosphamide"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "影响免疫系统且风险未知。"
            ],
            "safety_risk": [
              "主张使用需谨慎。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "临床应用安全性不明"
          ]
        },
        {
          "hypothesis_id": "H7",
          "score": 0.34,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_daclizumab"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "风险评估尚不明确。"
            ],
            "safety_risk": [
              "潜在的对肺部损害风险。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "需更多研究以确定影响"
          ]
        },
        {
          "hypothesis_id": "H8",
          "score": 0.31,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_methotrexate"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "已知肺部副作用，使用需谨慎。"
            ],
            "safety_risk": [
              "对肺部可能存在风险。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏明确剂量与疗效数据"
          ]
        },
        {
          "hypothesis_id": "H9",
          "score": 0.33,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_nintedanib"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "需进一步研究评估安全性。"
            ],
            "safety_risk": [
              "可能加重病情，需小心使用。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏独立研究支持其疗效"
          ]
        },
        {
          "hypothesis_id": "H10",
          "score": 0.32,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.3,
            "pk_pd_feasibility": 0.4,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.55,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_pirfenidone"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "可能影响病情且尚未明确其疗效。"
            ],
            "safety_risk": [
              "需要进一步研究其安全性。"
            ]
          },
          "confidence": "medium",
          "uncertainties": [
            "缺乏针对该疾病的信息和研究"
          ]
        },
        {
          "hypothesis_id": "H11",
          "score": 0.29,
          "components": {
            "mechanism_fit": 0.3,
            "class_prior": 0.2,
            "pk_pd_feasibility": 0.3,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.5,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_rituximab"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "对肺部损害风险未知。"
            ],
            "safety_risk": [
              "可能对既有病症加重。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏证据和临床数据支持"
          ]
        },
        {
          "hypothesis_id": "H12",
          "score": 0.27,
          "components": {
            "mechanism_fit": 0.2,
            "class_prior": 0.2,
            "pk_pd_feasibility": 0.3,
            "indication_plausibility": 0.4,
            "safety_risk": 0.5,
            "graph_bonus": 0.02,
            "conflict_penalty": 0.15
          },
          "graph_signals": {
            "support_weight": 0.45,
            "contradiction_weight": 0.85,
            "mechanistic_connectivity": false,
            "path_disjointness": 1,
            "conflict_hotspots": [
              {
                "topic": "Exacerbation of Pulmonary Fibrosis",
                "pro": [
                  "n_teriflunomide"
                ],
                "con": [
                  "n_ot1",
                  "n_ot2"
                ]
              }
            ]
          },
          "rationales": {
            "mechanism_fit": [
              "需要更多有效证据支持。"
            ],
            "safety_risk": [
              "潜在风险尚未评估。"
            ]
          },
          "confidence": "low",
          "uncertainties": [
            "缺乏足够数据支持其有效性和安全性"
          ]
        }
      ]
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "revisions": [
      {
        "hypothesis_id": "H1",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "对肺部纤维化的安全性",
            "expectation": "若存在显著安全风险，标注高权重的 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Abatacept",
            "via": [
              "Increased Fibrosis Risk",
              "Immunosuppression"
            ],
            "to": "Exacerbation of Pulmonary Fibrosis",
            "success_criteria": "形成至少两条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "评估免疫抑制对肺部纤维化发展的直接影响",
          "是否存在可接受的使用条件和风险评估"
        ]
      },
      {
        "hypothesis_id": "H2",
        "graph_actions": [
          {
            "type": "stress_test_safety",
            "topic": "对肺部纤维化的安全性",
            "expectation": "若存在显著安全风险，标注高权重的 refutes 边",
            "assignee": "Skeptic"
          },
          {
            "type": "add_mechanism_link",
            "from": "Adalimumab",
            "via": [
              "Increased Fibrosis Risk",
              "Immunosuppression"
            ],
            "to": "Exacerbation of Pulmonary Fibrosis",
            "success_criteria": "形成至少两条不相交路径",
            "assignee": "Proponent"
          }
        ],
        "debate_focus": [
          "是否有证据支持Adalimumab加重肺部纤维化的风险评估",
          "对比其他药物的风险与益处"
        ]
      }
    ],
    "pruned_hypotheses": [],
    "new_subhypotheses": [],
    "seed_request": {
      "should_regenerate": false,
      "reason": "现有候选药物的安全性争议集中，建议通过补充机制链与安全性评估逐步改善，暂不需要再生种子。",
      "n": 4
    }
  }
}